Annual Short Term Debt
N/A
December 31, 2023
Summary
- MRKR annual short term debt is not available.
Performance
MRKR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
September 30, 2024
Summary
- MRKR quarterly short term debt is not available.
Performance
MRKR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
MRKR Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MRKR Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Marker Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $665.10 K(+35.6%) |
| Sep 2022 | - | $490.40 K(-33.6%) |
| Jun 2022 | - | $738.40 K(+8.0%) |
| Mar 2022 | - | $684.00 K(+10.2%) |
| Dec 2021 | $620.50 K(+59.6%) | $620.50 K(+6.7%) |
| Sep 2021 | - | $581.60 K(+4.1%) |
| Jun 2021 | - | $558.70 K(+18.1%) |
| Mar 2021 | - | $473.10 K(+21.7%) |
| Dec 2020 | $388.80 K(+90.5%) | $388.80 K(+39.7%) |
| Sep 2020 | - | $278.30 K(-39.0%) |
| Jun 2020 | - | $456.10 K(+118.1%) |
| Mar 2020 | - | $209.10 K(+2.4%) |
| Dec 2019 | $204.10 K(>+9900.0%) | $204.10 K(+2.4%) |
| Sep 2019 | - | $199.30 K(+2.5%) |
| Jun 2019 | - | $194.50 K(+2.5%) |
| Mar 2019 | - | $189.80 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $5000.00(0.0%) |
| Jun 2018 | - | $5000.00(0.0%) |
| Mar 2018 | - | $5000.00(0.0%) |
| Sep 2017 | - | $5000.00(0.0%) |
| Jun 2017 | - | $5000.00(0.0%) |
| Mar 2017 | - | $5000.00(0.0%) |
| Dec 2016 | $5000.00(-90.6%) | $5000.00(0.0%) |
| Sep 2016 | - | $5000.00(-82.1%) |
| Jun 2016 | - | $28.00 K(0.0%) |
| Mar 2016 | - | $28.00 K(-47.2%) |
| Dec 2015 | $53.00 K(+0.2%) | $53.00 K(+0.2%) |
| Sep 2015 | - | $52.90 K(0.0%) |
| Jun 2015 | - | $52.90 K(0.0%) |
| Mar 2015 | - | $52.90 K(0.0%) |
| Dec 2014 | $52.90 K(-98.5%) | $52.90 K(0.0%) |
| Sep 2014 | - | $52.90 K(-88.1%) |
| Jun 2014 | - | $442.90 K(-14.9%) |
| Mar 2014 | - | $520.50 K(-85.1%) |
| Dec 2013 | $3.48 M(+124.0%) | $3.48 M(+32.1%) |
| Sep 2013 | - | $2.64 M(+3.9%) |
| Jun 2013 | - | $2.54 M(+24.3%) |
| Mar 2013 | - | $2.04 M(+31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.55 M(+40.5%) | $1.55 M(+12.6%) |
| Sep 2012 | - | $1.38 M(+8.2%) |
| Jun 2012 | - | $1.28 M(+10.4%) |
| Mar 2012 | - | $1.16 M(+4.5%) |
| Dec 2011 | $1.11 M(+42.1%) | $1.11 M(+933.5%) |
| Sep 2011 | - | $107.00 K(0.0%) |
| Jun 2011 | - | $107.00 K(+87.7%) |
| Mar 2011 | - | $57.00 K(-92.7%) |
| Dec 2010 | $778.10 K(+130.2%) | $778.10 K(+109.9%) |
| Sep 2010 | - | $370.70 K(+164.8%) |
| Jun 2010 | - | $140.00 K(-71.1%) |
| Mar 2010 | - | $485.00 K(+43.5%) |
| Dec 2009 | $338.00 K(-58.8%) | $338.00 K(+94.3%) |
| Sep 2009 | - | $174.00 K(+58.3%) |
| Jun 2009 | - | $109.90 K(-89.5%) |
| Mar 2009 | - | $1.05 M(+27.5%) |
| Dec 2008 | $820.00 K(+65.1%) | $820.00 K(+91.4%) |
| Sep 2008 | - | $428.50 K(-62.7%) |
| Jun 2008 | - | $1.15 M(+22.9%) |
| Mar 2008 | - | $934.40 K(+88.2%) |
| Dec 2007 | $496.60 K(-76.5%) | $496.60 K(+26.8%) |
| Sep 2007 | - | $391.60 K(+291.6%) |
| Jun 2007 | - | $100.00 K(-41.2%) |
| Mar 2007 | - | $170.00 K(-92.0%) |
| Dec 2006 | $2.11 M(+338.0%) | $2.11 M(+221.9%) |
| Sep 2006 | - | $656.80 K(-42.6%) |
| Jun 2006 | - | $1.14 M(+51.0%) |
| Mar 2006 | - | $758.10 K(+57.1%) |
| Dec 2005 | $482.70 K(+1.2%) | $482.70 K(+2.8%) |
| Sep 2005 | - | $469.70 K(+2.8%) |
| Jun 2005 | - | $456.70 K(-4.3%) |
| Dec 2004 | $477.10 K(+151.1%) | $477.10 K(+2.7%) |
| Sep 2004 | - | $464.60 K(+2.8%) |
| Jun 2004 | - | $452.10 K(+137.9%) |
| Dec 2001 | $190.00 K(-2.5%) | $190.00 K(+282.3%) |
| Mar 2001 | - | $49.70 K(-74.5%) |
| Dec 2000 | $194.80 K(+86.6%) | $194.80 K(+48.9%) |
| Sep 2000 | - | $130.80 K(+25.3%) |
| Jun 2000 | - | $104.40 K(-9.2%) |
| Mar 2000 | - | $115.00 K |
| Dec 1999 | $104.40 K | - |
FAQ
- What is the all time high annual short term debt for Marker Therapeutics?
- What is the all time high quarterly short term debt for Marker Therapeutics?
What is the all time high annual short term debt for Marker Therapeutics?
Marker Therapeutics all-time high annual short term debt is $3.48 M
What is the all time high quarterly short term debt for Marker Therapeutics?
Marker Therapeutics all-time high quarterly short term debt is $3.48 M